ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2168

The Smoking Paradox in the Development of Myocardial Infarction Among Rheumatoid Arthritis Patients

Uyen Sa D.T. Nguyen1, Yuqing Zhang2, Na Lu3, Jingbo Niu4, David T. Felson4, Michael P. Lavalley5, Jeffrey A. Sparks6, Shun-Chiao Chang7, Elizabeth W. Karlson8 and Hyon K. Choi3, 1Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 2Clinical Epidemilogy and Training Unit, Boston University School of Medicine, Boston, MA, 3Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 5Biostatistics, Boston University, Boston, MA, 6Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, 7Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 8Rheumatology, Brigham & Women's Hospital, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Epidemiologic methods, heart disease and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: ARHP III: Epidemiology and Public Health

Session Type: ARHP Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:
Smoking is a strong risk factor for myocardial infarction (MI), but not among
rheumatoid arthritis (RA) patients. These paradoxical findings may be due to index
event bias (a type of selection bias) which arises from selecting a group of
patients (e.g., RA) on the causal pathway (e.g., between smoking and MI); thus,
true risk factors may appear spuriously null or protective. We sought to identify
this
paradox,
and employ a sensitivity analysis to handle the unmeasured or uncontrolled
factor (U) that could partly explain the paradox. 

Methods: We used data
from The Health Improvement Network (THIN), an
electronic medical record database representative of the UK general population,
from 1995-2015. We analyzed data from adults (≥ 20 years) free of RA and
MI after at least 1 year of enrollment in the THIN database. Follow-up began
with first recording of smoking status after the 1-year enrollment and ended at
the time of MI, death, loss of follow-up, or the end of the study period, whichever came first. We assessed the effect of smoking
on MI using Cox regression in the general population, and restricting on
incident RA patients. We conducted a sensitivity analysis to correct for the
bias from U, by varying the prevalence of U and its association with MI.
Analyses were adjusted
for baseline confounders. 

Results: Of ~3.7
million subjects (mean age 46 years; 55% women; 28% current-smokers and 19%
ex-smokers), 16,061 developed incident RA of which 296 had incident MI. The
adjusted hazard ratio (HR) for current smoking and MI among RA patients was
1.56 (95%CI: 1.15, 2.12), whereas the corresponding HR in the general
population was 2.42 (95%CI: 2.37, 2.48) (Table).   On the additive
scale, the adjusted rate difference was 1.1 among RA patients, and 2.2 in the
general population. For the biased HR of 1.6, the corrected HR estimate ranged
from 1.60-2.57 when  the prevalence of U was set to  6% among smokers, with the
prevalence of U ranging from 20-30% in nonsmokers, and the association between
U and MI ranging from 2.0-4.0 (Figure).

Conclusion:
 We
demonstrated that conditioning on RA can bias the association between smoking
and MI toward the null, and provided a method to partly correct for this paradox. 
Since this bias could considerably mislead the conclusion about the
contribution of modifiable risk factors to important clinical outcomes,
investigators should consider appropriate design and analytic approaches to
avoid such
biases. 
 

 

Table. Association between Smoking and MI in the General Population and

Among RA Patients

 

 

 

Non-Smokers

Ex-smokers

Current Smokers

General Population

N=1,999,923

N=725,400

N=1,046,288

     Number of MI

19,073

12,317

17,137

     Total Follow-up Years

12,418,719

4,324,379

6,495,178

     Rate (1/1000 person-yr)

1.54

2.85

2.64

          Crude HR

1.0

1.81 (1.77, 1.86)

1.71 (1.67, 1.75)

          Adjusted HR*

1.0

1.24 (1.21, 1.28)

2.42 (2.37, 2.48)

 

 

 

 

  Among RA Patients

N=7,520

N=3,588

N=4,953

     Number of MI

124

66

106

     Total Follow-up Years

34,147

15,683

23,120

     Rate (1/1000 person-yr)

3.63

4.21

4.58

          Crude HR

1.0

1.25 (0.91, 1.72)

1.32 (0.99, 1.74)

          Adjusted HR*

1.0

1.03 (0.73, 1.44)

1.56 (1.15, 2.12)

Adjusted for age, sex, baseline body mass index and alcohol intake

 

Figure.
 Sensitivity Analysis of the Index Event Bias with a
Biased HR of 1.6

(Assuming
a 6% Prevalence of an Uncontrolled Factor (U) among Smokers)

       


Disclosure: U. S. D. T. Nguyen, None; Y. Zhang, None; N. Lu, None; J. Niu, None; D. T. Felson, None; M. P. Lavalley, None; J. A. Sparks, None; S. C. Chang, None; E. W. Karlson, None; H. K. Choi, None.

To cite this abstract in AMA style:

Nguyen USDT, Zhang Y, Lu N, Niu J, Felson DT, Lavalley MP, Sparks JA, Chang SC, Karlson EW, Choi HK. The Smoking Paradox in the Development of Myocardial Infarction Among Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-smoking-paradox-in-the-development-of-myocardial-infarction-among-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-smoking-paradox-in-the-development-of-myocardial-infarction-among-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology